Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125073302 | 12507330 | 2 | F | 20160802 | 20160629 | 20160816 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-049510 | BRISTOL MYERS SQUIBB | 65.00 | YR | F | Y | 0.00000 | 20160816 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125073302 | 12507330 | 1 | PS | COUMADIN | WARFARIN SODIUM | 1 | Oral | 39 MG, QWK | U | U | 9218 | 39 | MG | INJECTION | /wk | ||||
| 125073302 | 12507330 | 2 | SS | COUMADIN | WARFARIN SODIUM | 1 | U | U | 9218 | INJECTION | |||||||||
| 125073302 | 12507330 | 3 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 1 TAB, TID | U | 0 | 1 | DF | TID | ||||||
| 125073302 | 12507330 | 4 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 1 TAB, QID | U | 0 | 1 | DF | QID | ||||||
| 125073302 | 12507330 | 5 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | Intramuscular | 1000 ?G, TOTAL | U | 0 | 1000 | UG | |||||||
| 125073302 | 12507330 | 6 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | Oral | 1 TAB, TID | U | 0 | 1 | DF | TABLET | TID | |||||
| 125073302 | 12507330 | 7 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | Oral | 1 DF, BID | U | 0 | 1 | DF | CAPSULE | BID | |||||
| 125073302 | 12507330 | 8 | C | DULOXETINE. | DULOXETINE | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | CAPSULE | QD | |||||
| 125073302 | 12507330 | 9 | C | ENOXAPARIN | ENOXAPARIN | 1 | Subcutaneous | 60 MG, Q12H | U | 0 | 60 | MG | BID | ||||||
| 125073302 | 12507330 | 10 | C | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | Oral | 1 TAB, QWK | U | 0 | 1 | DF | /wk | ||||||
| 125073302 | 12507330 | 11 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Oral | 1 TAB, BID | U | 0 | 1 | DF | TABLET | BID | |||||
| 125073302 | 12507330 | 12 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Oral | 1 TAB, TID | U | 0 | 1 | DF | TABLET | TID | |||||
| 125073302 | 12507330 | 13 | C | ACETAMINOPHEN W/OXYCODONE | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | 1 TAB, QID | U | 0 | 1 | DF | QID | ||||||
| 125073302 | 12507330 | 14 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 100 MG, UNK | U | 0 | 100 | MG | TABLET | ||||||
| 125073302 | 12507330 | 15 | C | WARFARIN | WARFARIN | 1 | Unknown | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125073302 | 12507330 | 1 | Deep vein thrombosis |
| 125073302 | 12507330 | 2 | Pulmonary embolism |
| 125073302 | 12507330 | 3 | Anxiety |
| 125073302 | 12507330 | 5 | Product used for unknown indication |
| 125073302 | 12507330 | 6 | Muscle spasms |
| 125073302 | 12507330 | 7 | Product used for unknown indication |
| 125073302 | 12507330 | 8 | Product used for unknown indication |
| 125073302 | 12507330 | 9 | Product used for unknown indication |
| 125073302 | 12507330 | 10 | Product used for unknown indication |
| 125073302 | 12507330 | 11 | Product used for unknown indication |
| 125073302 | 12507330 | 12 | Product used for unknown indication |
| 125073302 | 12507330 | 13 | Pain |
| 125073302 | 12507330 | 14 | Product used for unknown indication |
| 125073302 | 12507330 | 15 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125073302 | 12507330 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125073302 | 12507330 | International normalised ratio fluctuation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |